Similarly, the efficacy of metabolic interventions in KEAP1-mutant tumours may be modulated by the gut microbiome [136], while microbiome-based interventions might help restore immune function in JAK1/2-mutant cases [141]. Here, KEAP1 is linked to neoplasm.